Unity Biotechnology, Inc. Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Unity Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Unity Biotechnology, Inc. for April 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Option Exercise | A | 5.95 | 800,000 | 4,760,000 | 800,000 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 150,000 | 0 | 300,000 | 150 K to 300 K (+100.00 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 120,000 | 0 | 150,000 | 30 K to 150 K (+400.00 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Ghosh Anirvan | Chief Executive Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Tompkins Tamara | See Remarks | Grant | A | 0.00 | 24,255 | 0 | 45,330 | 21.1 K to 45.3 K (+115.09 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 5.95 | 118,188 | 703,219 | 118,188 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Goeltz II Robert C. | Chief Financial Off ... | Grant | A | 0.00 | 29,106 | 0 | 163,510 | 134.4 K to 163.5 K (+21.66 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | David Nathaniel E | President | Grant | A | 0.00 | 24,255 | 0 | 2,323,986 | 2.3 M to 2.3 M (+1.05 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Marquess Dan | Chief Scientific Of ... | Grant | A | 0.00 | 24,255 | 0 | 381,297 | 357 K to 381.3 K (+6.79 %) |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Option Exercise | A | 5.95 | 98,490 | 586,016 | 98,490 | |
| Apr 01 2020 | UBX | Unity Biotechnolog ... | Dananberg Jamie | Chief Medical Offic ... | Grant | A | 0.00 | 24,255 | 0 | 454,702 | 430.4 K to 454.7 K (+5.63 %) |